Innovative regenerative medicines in the EU: a better future in evidence?
Crossref DOI link: https://doi.org/10.1186/s12916-017-0818-4
Published Online: 2017-03-08
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Corbett, Mark S.
Webster, Andrew
Hawkins, Robert
Woolacott, Nerys
Funding for this research was provided by:
Health Technology Assessment Programme (Project No 14/151/06)